Supplementary materials: Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients.pdf

Supplementary Figure
1. Flow diagram summarizing the number of patients with medication data
available at each encounter across the two study populations.
Supplemental Table 1.
List of 65 medications collected in the PCI and allo-HCT populations with
corresponding CPIC
level of evidence and FDA evidence classification (sorted alphabetically).
Supplementary Table
2. Summary of CYP2C19 Simulation Analysis
Supplementary Table
3. Summary of CYP2D6 Simulation Analysis

Supplementary Table 4. Summary of Simulation
Analysis for additional genes